Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
5.71
+0.21 (3.82%)
Jul 23, 2025, 2:58 PM - Market open
Vivos Therapeutics Employees
Vivos Therapeutics had 109 employees as of December 31, 2024. The number of employees decreased by 14 or -11.38% compared to the previous year.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$134,202
Profits / Employee
-$103,092
Market Cap
33.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
VVOS News
- 27 days ago - New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children - GlobeNewsWire
- 2 months ago - Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call - GlobeNewsWire
- 3 months ago - Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada - GlobeNewsWire
- 4 months ago - Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 months ago - Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call - GlobeNewsWire
- 7 months ago - Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire